Searched for
PHARMA INDUSTRY
India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
- SCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilitiesNew identity reinforces the company’s focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions
- Sensex, Nifty fall as IT stocks slide, rising oil prices weighIndian equity markets took a hit on Wednesday, primarily due to declines in the IT sector and escalating crude oil prices. Both the Sensex ...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...
- Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini PiramalIn a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The ...
- India, Mexico begin talks for trade pact; aim to boost commerce, investmentsIndia and Mexico have initiated negotiations for a preferential trade agreement to enhance bilateral trade and investment. The agreement ai...
- QClairvoyance's quantum chemistry bet: Transitioning from research to pharma partnershipsQClairvoyance Quantum Labs has performed chemically precise simulations of eight small molecules on an actual quantum computer, marking pro...
- Stocks in news: Jio Platforms, RIL, Infosys, L&T, Tata Capital, Waaree Energies and Vedanta IronIndian benchmark indices saw a volatile session amid the Nifty and Bank Nifty monthly expiry. Stocks like Jio Platforms made headlines foll...
- India to remain top of the Asian pie for AdventAdvent International has successfully raised $30 billion for its global buyout and mid-market funds. The firm plans to invest significantly...
- Worried about long-term returns? No equity mutual fund lost money on 5- and 7-year SIPsNo equity mutual fund delivered negative SIP returns over five- and seven-year periods, an ETMutualFunds analysis found. Quant Small Cap Fu...
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
- Indian pharma: Unethical practices, marketing rules under lens; new review body set upThe review comes against the backdrop of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which was introduced in 2015 as a...
- ET Industry Changemakers Awards North 2026: Celebrating Visionaries Who Are Shaping Tomorrow
- GDHS 2026 to focus on implementing AI actionScheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- NATCO Pharma subsidiary launches Carboplatin in US market to address shortagesIndian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market b...
- Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...
Load More
